Cargando…
Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories
Diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone significant changes over the duration of the pandemic. In early 2020, SARS-CoV-2 specific nucleic acid testing (NAT) protocols were predominantly in-house assays developed based on protocols published i...
Autores principales: | Lau, Katherine A., Kaufer, Alexa, Gray, Joanna, Theis, Torsten, Rawlinson, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Pathologists of Australasia. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012950/ https://www.ncbi.nlm.nih.gov/pubmed/35440366 http://dx.doi.org/10.1016/j.pathol.2022.01.006 |
Ejemplares similares
-
Proficiency testing for SARS-CoV-2 whole genome sequencing
por: Lau, Katherine A., et al.
Publicado: (2022) -
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent
por: Kaufer, Alexa M., et al.
Publicado: (2020) -
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
por: Stein, Derek R., et al.
Publicado: (2021) -
Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories
por: Lieberman, Joshua A., et al.
Publicado: (2020) -
Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories
por: Mögling, Ramona, et al.
Publicado: (2022)